-
More institutional review boards are seeing proposals for studies involving some type of genetic research, but many IRB members feel unprepared to appropriately review the study design and assess the potential risks involved.
-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-
Insulin Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB
and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and
Diabetes; Ultralow-Dose Estrogen and Bone in Older Women; Effect of
Intensity of Oral Anticoagulation in Atrial Fibrillation; Patient
Knowledge and Awareness of Hypertension
-
-
Infertility is a common condition and usually presents to the primary care physician initially. Infertility is defined as 1 year of unprotected intercourse in which a pregnancy has not been achieved. Fifteen to twenty percent of couples in the United States are infertile, and this rate has remained relatively stable since the early 1980s.
-
-
Are you making strides on the salary front? If the answer is no, count yourself among the majority of family planning providers.
-
Today, more than 6 million women of reproductive age rely on Medicaid for their basic health care, including family planning services.
-
More women are taking a second look at intrauterine devices (IUDs), and not all of them are considering such use for contraception.
-
While medical and reproductive rights groups have petitioned the Food and Drug Administration to make emergency contraception (EC) available over the counter (OTC), many clinicians are less than enthusiastic when it comes to such availability for oral contraceptives (OCs). Why?